Trials / Conditions / Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
4 registered clinical trials studyying Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Suspended | Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diag NCT04799275 | National Cancer Institute (NCI) | Phase 2 / Phase 3 |
| Completed | Combination Chemotherapy and TAK-659 as Front-Line Treatment in Treating Patients With High-Risk Diffuse Large NCT03742258 | Northwestern University | Phase 1 |
| Active Not Recruiting | Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lympho NCT03038672 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Nanochip Technology in Monitoring Treatment Response and Detecting Relapse in Participants With Diffuse Large NCT03656835 | Ohio State University Comprehensive Cancer Center | N/A |